Can Young Blood Help an Old Brain?

Young Human Blood Improves Brain Function in Old Mice

A 2017 study published in Nature3 presents evidence that a protein found in human blood plasma from young people helps improve brain function in old mice. For decades scientists have posited that "young blood" can reverse the symptoms of aging, such as loss of memory and reductions in muscle function and metabolism.

While previous studies using mouse-to-mouse transfers of "young blood" have demonstrated its rejuvenating properties on older mice, researchers suggest this is the first time a human blood protein has been shown to trigger similar anti-aging effects in older mice.

To date, at least two U.S.-based companies have launched clinical trials in an attempt to bring this research to bear on human subjects. In those trials, elderly people receive blood from younger adult donors, after which physical qualities in the older adults are evaluated for potential improvements.

Blood From Human Umbilical Cords

In one of the clinical trials, researchers at California's Stanford University School of Medicine demonstrated human blood plasma can improve the memory and learning abilities of older mice. Their tests involved infusing plasma from the umbilical cords of newborn babies into the veins of elderly mice.

With improved brain function due to the plasma infusion, the mice were able to, for example, more effectively navigate mazes and learn to avoid areas of their cages wired to deliver electrical shocks. These outcomes suggest something in young blood appears to be vital to maintaining mental acuity.

Because several behavioral and biological characteristics of mice closely resemble those of humans, it may follow that young blood plasma has the potential to boost cognitive ability in older humans, but more research is needed. According to the trial's lead author Joseph Castellano, neurology instructor at Stanford University School of Medicine, the findings may support future exploration of new drugs targeting the dementia process.

"Part of what makes this exciting is it suggests there's more communication between the blood and brain than we've thought," Castellano said. The current study follows earlier work performed by the same team, in which old mice showed improvements in learning and memory after receiving plasma infusions from young mice.

The aim of the new research was to investigate whether young human blood also might have similar beneficial effects on older mice. According to CBS News, while several types of human blood were tested, only blood plasma from umbilical cords had noteworthy positive effects. Plasma from young adults, ages 19 to 24, was less effective, and plasma from older adults, ages 61 to 82, yielded no benefits at all.

The Benefits of Platelet-Rich Plasma Therapy

In the past decade, medical professionals have been using platelet-rich plasma (PRP) therapy to release growth factors that help heal and strengthen areas of the human body. As you may know, platelets are an important part of your body's healing process — they're responsible for blood clotting and are among the "first responders" to an injury site. By forming a clot, platelets stop bleeding.

In the process, platelets open up and spill out the growth factors held inside. These growth factors act as signaling molecules, issuing the instructions needed to call forth your body's resources to repair damaged tissue. To avoid confusion, while some stem cells may be present in PRP therapy, stem-cell therapy is its own separate and more sophisticated process.

Blood Based Rejuvenation Therapy

So called "vampire facelifts" are another phenomenon born out of the potential rejuvenating power of blood. In this case, your own blood is drawn and spun in a centrifuge to separate the platelets from the red blood cells. The platelets and a mix of natural fillers are then injected back into your face, which is said to smooth lines and reduce wrinkles.

Unfortunately, the procedure is costly roughly $800 to $1,500 per session — and the results are only temporary. Perhaps more intriguing are studies showing PRP may promote wound healing and help your body recover from injuries. Research published in Plastic and Reconstructive Surgery11 suggests growth factors released from activated platelets effectively support wound healing in both soft and hard tissues.

Clinical Trial Touts Benefits of Young Blood

Entrepreneur Jesse Karmazin launched Ambrosia in 2016, focusing on bringing the concept of "young blood" to human beings. As mentioned, according to Business Insider, if you are age 35 or older, you qualify to participate in Karmazin's pay-to-participate trial. For $8,000 and two days of your time, you will receive 1.5 liters of plasma from a donor between the ages of 16 and 25.

In case you're curious about the company's name, according to ancient Greek myths, Ambrosia referred to the food or drink of immortal Greek gods, the belief being that anyone who consumed such food or drink would have longevity or immortality bestowed upon them.

Karmazin claims most participants see improvements within a month after a single plasma infusion. Scientists and clinicians are skeptical about Karmazin's methods, suggesting his trial is poorly designed and therefore unable to produce scientific evidence demonstrating the effectiveness of the transfusions. Others look down on his methods because it is a paid trial.

Although Karmazin suggests the inspiration for his work comes from earlier studies involving parabiosis with lab mice, his trial for humans does not involve parabiosis, nor does it include a control group, which is common in lab trials. Karmazin says it would not be fair to use a control group or placebos because his clients are paying for the infusion.

As of December 15, 2016, 25 people had been infused with "young blood" at Ambrosia. Karmazin claims participants are seeing "miraculous results," including a woman with chronic fatigue syndrome who claims to "feel healthy for the first time" and "looks younger." Jonathan Kimmelman, a bioethicist at McGill University in Montreal, shared with MIT Technology Review what I think is certainly a valid concern about Ambrosia.

subscribe